BlackRock Capital Allocation Term Trust (BCAT) Stock Price, News & Analysis
Company Description
BlackRock Capital Allocation Term Trust (NYSE: BCAT) is classified in the asset management industry within the Financial Services sector and carries a market capitalization of $1.6B, ranking #2,487 among all listed U.S. companies by market cap.
BCAT has gained 2.6% over the past year, placing it at #1,718 in year-to-date performance among tracked companies. Shares last traded at $15.31.
This page collects what Stock Titan holds for BCAT, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BlackRock Capital Allocation Term Trust (BCAT) stock last closed at $15.31. Over the past 12 months, the stock has gained 2.6%, ranking #1,959 in 52-week price change. At a market capitalization of $1.6B, BCAT is classified as a small-cap stock with approximately 104.8M shares outstanding.
BCAT Rankings
Latest News
BlackRock Capital Allocation Term Trust has 6 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 2 with negative movement. Key topics include conferences. View all BCAT news →
SEC Filings
BlackRock Capital Allocation Term Trust has filed 5 recent SEC filings, including 3 Form 4, 1 Form N-CEN, 1 Form N-CSR. The most recent filing was submitted on July 15, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BCAT SEC filings →
Insider Radar
Insider selling at BlackRock Capital Allocation Term Trust over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.
Financial Highlights
Upcoming Events
Short Interest History
Short interest in BlackRock Capital Allocation Term Trust (BCAT) currently stands at 1.2 million shares, up 9.1% from the previous reporting period, representing 1.1% of the shares outstanding. Since July 2025, short interest has increased by 698.5%.
Days to Cover History
Days to cover for BlackRock Capital Allocation Term Trust (BCAT) currently stands at 1.9 days, up 38.7% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 90% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1.9 days.
BCAT Company Profile & Sector Positioning
BlackRock Capital Allocation Term Trust (BCAT) operates in the Asset Management industry within the broader Financial Services sector and is listed on the NYSE. Among dividend-paying stocks, BCAT ranks #17 by dividend yield. In monthly performance, the stock ranks #2,258 among all tracked companies.
Investors comparing BCAT often look at related companies in the same sector, including BlackRock ESG Capital Allocation Term Trust (ECAT), Eaton Vance Tax-Managed Buy-Write Opportunities Fund (ETV), BlackRock Enhanced Equity Dividend Fund (BDJ), MORGAN STANLEY DIRECT LENDING (MSDL), and BlackRock Science and Technology Term Trust (BSTZ). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BCAT's relative position within its industry.